Medipal Holdings Stock Key Fundamental Indicators
| MEPDF Stock | USD 19.00 0.00 0.00% |
As of the 16th of February 2026, MediPal Holdings secures the Mean Deviation of 0.4522, standard deviation of 1.87, and Risk Adjusted Performance of 0.105. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MediPal Holdings, as well as the relationship between them. Please verify MediPal Holdings mean deviation, variance, as well as the relationship between the Variance and maximum drawdown to decide if MediPal Holdings is priced some-what accurately, providing market reflects its recent price of 19.0 per share. Given that MediPal Holdings has variance of 3.48, we recommend you to check MediPal Holdings's last-minute market performance to make sure the company can sustain itself at a future point.
MediPal Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MediPal Holdings' valuation are provided below:MediPal Holdings does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. MediPal |
MediPal Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MediPal Holdings' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MediPal Holdings.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in MediPal Holdings on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding MediPal Holdings or generate 0.0% return on investment in MediPal Holdings over 90 days. MediPal Holdings is related to or competes with Shandong Weigao, Santen Pharmaceutical, Shandong Weigao, United Laboratories, Ansell, and Amplifon SpA. Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan More
MediPal Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MediPal Holdings' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MediPal Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0856 | |||
| Maximum Drawdown | 15.15 |
MediPal Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MediPal Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MediPal Holdings' standard deviation. In reality, there are many statistical measures that can use MediPal Holdings historical prices to predict the future MediPal Holdings' volatility.| Risk Adjusted Performance | 0.105 | |||
| Jensen Alpha | 0.2074 | |||
| Total Risk Alpha | 0.081 | |||
| Treynor Ratio | 1.08 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MediPal Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MediPal Holdings February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.105 | |||
| Market Risk Adjusted Performance | 1.09 | |||
| Mean Deviation | 0.4522 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 1.87 | |||
| Variance | 3.48 | |||
| Information Ratio | 0.0856 | |||
| Jensen Alpha | 0.2074 | |||
| Total Risk Alpha | 0.081 | |||
| Treynor Ratio | 1.08 | |||
| Maximum Drawdown | 15.15 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
MediPal Holdings Backtested Returns
MediPal Holdings appears to be very steady, given 3 months investment horizon. MediPal Holdings has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for MediPal Holdings, which you can use to evaluate the volatility of the firm. Please exercise MediPal Holdings' Standard Deviation of 1.87, mean deviation of 0.4522, and Risk Adjusted Performance of 0.105 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MediPal Holdings holds a performance score of 10. The company secures a Beta (Market Risk) of 0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MediPal Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding MediPal Holdings is expected to be smaller as well. Please check MediPal Holdings' variance, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether MediPal Holdings' current price movements will revert.
Auto-correlation | 0.00 |
No correlation between past and present
MediPal Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between MediPal Holdings time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MediPal Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current MediPal Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 1.56 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, MediPal Holdings has a Return On Asset of 0.0169. This is 100.19% lower than that of the Healthcare sector and 99.42% lower than that of the Medical Distribution industry. The return on asset for all United States stocks is 112.07% lower than that of the firm.
MediPal Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MediPal Holdings's current stock value. Our valuation model uses many indicators to compare MediPal Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MediPal Holdings competition to find correlations between indicators driving MediPal Holdings's intrinsic value. More Info.MediPal Holdings is regarded third in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 0.30 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for MediPal Holdings is roughly 3.32 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MediPal Holdings' earnings, one of the primary drivers of an investment's value.MediPal Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MediPal Holdings' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MediPal Holdings could also be used in its relative valuation, which is a method of valuing MediPal Holdings by comparing valuation metrics of similar companies.MediPal Holdings is currently under evaluation in return on asset category among its peers.
MediPal Fundamentals
| Return On Equity | 0.0561 | |||
| Return On Asset | 0.0169 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 1.24 B | |||
| Shares Outstanding | 209.96 M | |||
| Shares Owned By Insiders | 9.02 % | |||
| Shares Owned By Institutions | 27.34 % | |||
| Price To Earning | 15.57 X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 0.0008 X | |||
| Revenue | 3.29 T | |||
| Gross Profit | 217.44 B | |||
| EBITDA | 71.64 B | |||
| Net Income | 29.42 B | |||
| Cash And Equivalents | 237.6 B | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 1.21 X | |||
| Book Value Per Share | 2,629 X | |||
| Cash Flow From Operations | 61.22 B | |||
| Earnings Per Share | 0.95 X | |||
| Number Of Employees | 12.8 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 2.79 B | |||
| Total Asset | 1.71 T | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 1.71 T | |||
| Last Dividend Paid | 46.0 |
About MediPal Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MediPal Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MediPal Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MediPal Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan. MEDIPAL HOLDINGS operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 12801 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in MediPal Pink Sheet
MediPal Holdings financial ratios help investors to determine whether MediPal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MediPal with respect to the benefits of owning MediPal Holdings security.